Searched for
SPECIALITY INJECTABLE BUSINESS
Vedanta listing: How billionaire Anil Agarwal's 'Fantastic 5' unlocked Rs 63,500 crore value with mega demergerVedanta’s long-awaited demerger culminated with the listing of four newly spun-off businesses, triggering a sharp market re-rating and unlo...- Avammune’s big bet: Why the future of cancer treatment may come in a pillAs global oncology races toward next-generation therapies, Avammune Therapeutics is betting on affordable, orally administered immunotherap...
- Textile sector: Time for a relook as tariff tantrum may soon be history? 5 textile stocks with upside potential of up to 27%The Indian textile and apparel sector has had a stressful year. The US tariffs disrupted orders to the sector’s largest market, squeezed ma...
- Stock picks of the week: 5 stocks with consistent score improvement and upside potential of up to 27% in 1 yearAfter the correction, the street will reach a stage where, if a company delivers numbers, there will be enough money waiting to move into t...
- For both the compulsive trader and careful investor: 25 stocks to watch if risk appetite returns; some with upside potential, some notIf the price of crude oil softens, Indian equities may again see a risk-on phase. Tariff concerns are no longer the central issue; the larg...
- Venus Remedies gets Saudi FDA approval for speciality oncology therapyVenus Remedies Limited has secured its first global marketing authorization for its specialty oncology therapy, Plerixafor, from the Saudi ...
- These large-caps have ‘strong buy’ & ‘buy’ recos and an upside potential of up to 25%Here’s a thing investors in equity need to keep in mind. A large part of the upmove one might see in the next one or two trading sessions w...
- Holding stocks is harder than finding them: 10 mid- and small-caps stocks that may be worth holding on toHolding a stock is not an act of blind faith. It is not refusing to change one’s mind. It is not averaging down because the stock has falle...
- Stock picks of the week: 5 stocks with consistent score improvement and upside potential of up to 29%In the current phase of market volatility, the only solace to be derived is from market history. And history tells us that, just like good ...
- Sun Pharma deal: Perception changer for Indian pharma sector? 10 pharma stocks with upside potential of up to 38%The Indian pharma sector made its initial global forays almost a quarter century ago. Companies sought out markets abroad, learnt to deal w...
- Kolkata Port: Decline in number of voters during SIR brings in uncertainty in TMC bastionVoter numbers have significantly dropped in Kolkata Port Assembly constituency. This has created uncertainty for the ruling Trinamool Congr...
- Jubilant Pharmova's US arm prepays Rs 626 crore term loanJubilant Pharmova's US subsidiary secured a $75 million term loan, as of March 31, 2024, the company's gross debt stood at Rs. 3,414 crore ...
- Aurobindo puts its injectables business on the block, againAurobindo Pharma promoters have begun the process of selling a majority stake in its injectables business, Eugia Pharma Specialities, after...
- Dr Reddy's joins hands with Gland Pharma to market 8 ANDAs in USDr Reddy's is developing its injectable business and recently launched Paricalcitol injection, a therapeutic equivalent generic version of ...
- Big pharma eyes takeover of Claris’ injectables business for Rs 2500-Rs 3000 croreCarlyle private equity backed CLL has transferred its speciality injectables business into a wholly owned subsidiary called CIL.
- Claris Lifesciences completes transfer of Speciality Injectable BusinessShareholders of the company approved the transfer along with all employees, assets and liabilities at a consideration not less than its boo...
- Claris Lifesciences inks JV with Japanese drug maker Otsuka Pharma & Mitsui for Indian marketAhmedabad-based Claris Lifesciences Limited, India executed agreements for a Joint Venture with two Japan-based drug makers Otsuka Pharmace...
- Strides to acquire Aspen's Brazilian facility for $75 mnPharma firm Strides Arcolab today said it has entered into an agreement with South Africa-based Aspen to acquire the latters facility in Br...
- General Atlantic eyes stake in Strides armPrivate equity firm General Atlantic (GA) is in advanced talks with Strides Arcolabs to buy a significant minority stake in the Bangalore-b...
- PE funds eye stake in Strides' injectables bizPrivate equity funds Carlyle Group and 3i, are among those holding preliminary discussions to take a substantial minority stake in pharmace...
Load More
